Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Cytotoxic gigantecin analogue presented at ACS meeting

Sep. 3, 1998

WHI reports design, synthesis and pharmacological evaluation of new agent for glioblastoma

Sep. 3, 1998

FDA advisory committee recommends clearance for Valstar

Sep. 3, 1998

Nolvadex recommended for approval in U.S., to be copromoted by Zeneca and Roche

Sep. 3, 1998

Antitumor imidazoacridone available for licensing from BTG

Sep. 3, 1998

Protegrin analogue safe in cancer patients receiving chemotherapy

Sep. 3, 1998

Novartis describes search for potent and selective CDK1/CDK2 inhibitors

Sep. 2, 1998

AEterna isolates molecule exhibiting anti-MMP activity

Sep. 2, 1998

Orphan drug designation granted for thalidomide in KS

Sep. 1, 1998

News from the ACS: Btk inhibitor LFM-A13 promotes apoptosis in leukemia cells

Sep. 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...